ArticleJournal of cancer research and clinical oncology2024

Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia.

Zhao Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.